Journal article
A multicenter, large-sample, randomized clinical trial on improving the median survival time of advanced non-small cell lung cancer by combination of Ginseng Rg3 and chemotherapy
Abstract
Objective To observe the efficacy of the combination of chemotherapy and Ginseng Rg3 on advanced non-small cell lung cancer(NSCLC). Methods In the multi-center, large-sample, randomized, double blind trial, 414 patients with Ⅲ-Ⅳ NSCLC were enrolled.199 were in the experimental group and 215 the control group. The patients in the experimental group were treated with the standard first-line chemotherapy combined with Ginseng Rg3. The patients …
Authors
Zhang Y; Wang X; Liu H; Liu J; Hou W; Lin H
Journal
Chinese Journal of Oncology, Vol. 40, No. 4, pp. 295–299
Publication Date
April 23, 2018
DOI
10.3760/cma.j.issn.0253-3766.2018.04.011
ISSN
0253-3766